aTyr Pharma (ATYR)

• Market cap: $84.9M
• 1 day: -2.48%
• 5 days: -10.72%
• 1 month: 20.04%
• 3 months: -81.65%
• 6 months: -75.04%
• Year to date: -77.85%
• 1 year: -72.24%
• 5 years: -71.79%
• 10 years: -99.52%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Employees: 59